Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Bioxyne Limited ( (AU:BXN) ).
Bioxyne Limited has announced the quotation of 18 million ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 27, 2025. This move, part of an employee incentive scheme, is expected to enhance the company’s market presence and potentially increase shareholder value by expanding its capital base.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its innovative solutions in probiotics and immune health, targeting both domestic and international markets.
Average Trading Volume: 4,309,804
Technical Sentiment Signal: Buy
Current Market Cap: A$91.22M
See more insights into BXN stock on TipRanks’ Stock Analysis page.